Clinical trial
A Non-interventional Post-registration Clinical Study of Efficacy and Safety of Qutenza in Patients With Post-operative Peripheral Neuropathic Pain
NCT02171182 is registered in ClinicalTrials.gov with Astellas Pharma s.r.o. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Non-interventional Post-registration Clinical Study of Efficacy and Safety of Qutenza in Patients With Post-operative Peripheral Neuropathic Pain
- Lead sponsor
- Astellas Pharma s.r.o.
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2014
- Completion date
- August 31, 2015
- Enrollment
- 319 (actual)
- Sites
- 29
Conditions
As the registry lists them; a condition with its own page is linked.
post-operative peripheral neuropathic pain